Development of a rapid, quantitative method for LDL subfractionation with use of the Quantimetrix Lipoprint LDL System.
about
Paraoxonase 1 gene polymorphism does not affect clopidogrel response variability but is associated with clinical outcome after PCIAssociation of serum retinol binding protein 4 with atherogenic dyslipidemia in morbid obese patientsApplication of machine learning algorithms to predict coronary artery calcification with a sibship-based design.Small Dense Low-Density Lipoprotein as Biomarker for Atherosclerotic Diseases.Reference values assessment in a Mediterranean population for small dense low-density lipoprotein concentration isolated by an optimized precipitation methodLess but better: cardioprotective lipid profile of patients with GCK-MODY despite lower HDL cholesterol level.The effects of treatment on lipoprotein subfractions evaluated by polyacrylamide gel electrophoresis in patients with autoimmune hypothyroidism and hyperthyroidismPrevalence of LDL atherogenic phenotype in patients with systemic lupus erythematosus.LDL-migration index (LDL-MI), an indicator of small dense low-density lipoprotein (sdLDL), is higher in non-alcoholic steatohepatitis than in non-alcoholic fatty liver: a multicenter cross-sectional study.LDL cholesterol estimation in patients with the metabolic syndrome.Comparison of effects of diet versus exercise weight loss regimens on LDL and HDL particle size in obese adults.Asthma and metabolic syndrome: Current knowledge and future perspectives.Association of small dense LDL serum levels and circulating monocyte subsets in stable coronary artery disease.Smaller Mean LDL Particle Size and Higher Proportion of Small Dense LDL in Korean Type 2 Diabetic Patients.The effect of PPARgamma-agonism on LDL subclass profile in patients with type 2 diabetes and coronary artery disease.Effects of Oral L-Citrulline Supplementation on Lipoprotein Oxidation and Endothelial Dysfunction in Humans with Vasospastic AnginaImproved efficacy for ezetimibe and rosuvastatin by attenuating the induction of PCSK9Metabolic profile in two physically active Inuit groups consuming either a western or a traditional Inuit diet.Lack of association between low density lipoprotein particle size and on-treatment platelet reactivity in patients with coronary artery disease.Ethnic differences in low-density lipoprotein particle size in hypertensive adults.Effect of short term aerobic exercise on fasting and postprandial lipoprotein subfractions in healthy sedentary men.Systemic Inflammatory Markers Are Closely Associated with Atherogenic Lipoprotein Subfractions in Patients Undergoing Coronary AngiographyIntermittent fasting combined with calorie restriction is effective for weight loss and cardio-protection in obese women.Improvement in coronary heart disease risk factors during an intermittent fasting/calorie restriction regimen: Relationship to adipokine modulations.Effects of Armolipid Plus on small dense LDL particles in a sample of patients affected by familial combined hyperlipidemia.Increased Small Dense LDL and Decreased Paraoxonase Enzyme Activity Reveals Formation of an Atherogenic Risk in Streptozotocin-Induced Diabetic Guinea Pigs.Effect of insulin analog initiation therapy on LDL/HDL subfraction profile and HDL associated enzymes in type 2 diabetic patients.HDL subfractions and very early CAD: novel findings from untreated patients in a Chinese cohort.Significance of small dense low-density lipoprotein as a risk factor for coronary artery disease and acute coronary syndrome.Effect of TAK-085 on Low-density Lipoprotein Particle Size in Patients with Hypertriglyceridemia: A Double-blind Randomized Clinical Study.Persistence of an atherogenic lipid profile after treatment of acute infection with Brucella.Large HDL Subfraction But Not HDL-C Is Closely Linked With Risk Factors, Coronary Severity and Outcomes in a Cohort of Nontreated Patients With Stable Coronary Artery Disease: A Prospective Observational Study.Insulin Resistance Predicts Atherogenic Lipoprotein Profile in Nondiabetic Subjects.Association between body shape index and small dense LDL particles in a cohort of mediterranean women: findings from Progetto ATENAIn vivo triglyceride synthesis in subcutaneous adipose tissue of humans correlates with plasma HDL parametersA rapid 3% polyacrylamide slab gel electrophoresis method for high through put screening of LDL phenotype.Serum obestatin level strongly correlates with lipoprotein subfractions in non-diabetic obese patients.Transcriptomic analysis of the liver of cholesterol-fed rabbits reveals altered hepatic lipid metabolism and inflammatory response.CVD Risk Stratification in the PCSK9 Era: Is There a Role for LDL Subfractions?Plasminogen Activator Inhibitor-1 Level Correlates with Lipoprotein Subfractions in Obese Nondiabetic Subjects.
P2860
Q28486151-9AA51D8E-772E-43D9-B4F6-C47C346ED7B4Q28534795-C00F70B2-6D89-459F-ABE2-B7F540D33E15Q33689552-96628DC8-0A21-4FF5-9292-22EC7F1CF587Q33717612-A62C7D13-8253-4CEC-A7C8-142C3B6FC2CAQ33803712-BB4E70CE-91EC-489C-8346-DE942F3D15D5Q34023089-B719995F-BFD8-4166-9A1A-F9D476EFF915Q34410638-58FA7BC1-9D45-425E-BF0D-C620EEA5E548Q34627711-68D22F4D-1701-4255-A7C1-ED637FF14508Q34776084-DE033803-75F3-424F-8DD0-B9C42E40FCF3Q34997089-1F95D168-25C3-464F-8BE6-2DBDCB8C2213Q35147584-F474E1C3-1E36-4269-A0B6-78DD1BB2981CQ35179339-3BA3E3B2-D2C8-465A-AA92-2BF81AAF2E08Q35302588-E16A0E2E-76A2-4BD9-B4AE-75ABFC407FBAQ35564087-666340D6-8238-4037-B72D-776E238510C5Q35612747-9197BBFF-6D87-466E-B526-7F9BAF557F2EQ35618773-AAFEB976-5992-4824-BEE7-B1A726D167B7Q35771131-AFDDA83C-140A-45DD-99B7-F6DFCF9E3B6CQ36159590-912A1C1F-6B53-47C5-9148-9824A1DA0C6CQ36223078-E0CC3DF3-F38F-477F-B3A2-B0928314A732Q36252520-61079781-B63A-46AA-B40B-97CE03CF9115Q36317195-8FAA0C62-2175-4D1D-BC60-E3FBFDEA3C76Q36356620-6A1E9C5A-7770-4D82-BB1A-2207EFD0EDE1Q36437259-8A9EA5AE-0006-46F7-9D6C-B4F91FB682F2Q36444966-F16FC7D4-3C4A-4A35-8D2C-1F324E36CF85Q36767154-1361A9CE-6035-4CFE-BC04-4B41FDF784A7Q36825726-A1C0686C-AF50-4D83-8048-CB7CA3BD78AAQ36843216-4CC52B8D-C393-4E2D-ACCB-420ADAA32CCCQ37151344-564B402F-E4C7-4A86-8BE8-1A89CF72F91EQ37206847-3766D07C-7387-4DE0-A1F6-E48F7BC1FFE9Q37334006-5829EAB9-796E-409D-A402-6B2FE8B29517Q37430645-DBDDF4C8-08C8-4149-ABE2-D626257984C2Q37624112-21555F82-B73E-4B32-9D6D-E419638F58BAQ41622735-8D5D482F-4A5D-4083-8CEE-37F2E077D8B1Q41685512-00FDA777-F7A9-48E3-A17B-FEC1C08E7DCFQ42359779-136A54EB-FDDD-487C-8B3B-A0B438264CD7Q43223742-072702A7-76FB-4DC0-81EC-21BC306AEDCAQ53080484-50346F91-F8D1-4465-ABFA-B0162DDD727FQ55341000-41EFB79C-93F3-497F-8055-571441BCCA6AQ55409636-B3F7CC81-B82F-4E25-BFB2-07280B89DF59Q55555524-7B549FAA-CA84-4EDA-AC4E-EC7B3309E6C6
P2860
Development of a rapid, quantitative method for LDL subfractionation with use of the Quantimetrix Lipoprint LDL System.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Development of a rapid, quanti ...... timetrix Lipoprint LDL System.
@ast
Development of a rapid, quanti ...... timetrix Lipoprint LDL System.
@en
type
label
Development of a rapid, quanti ...... timetrix Lipoprint LDL System.
@ast
Development of a rapid, quanti ...... timetrix Lipoprint LDL System.
@en
prefLabel
Development of a rapid, quanti ...... timetrix Lipoprint LDL System.
@ast
Development of a rapid, quanti ...... timetrix Lipoprint LDL System.
@en
P2093
P1433
P1476
Development of a rapid, quanti ...... timetrix Lipoprint LDL System.
@en
P2093
Hoefner DM
McConnell JP
Meissner I
O'Brien JF
P304
P407
P577
2001-02-01T00:00:00Z